Hologic/Cytyc Merger Combines Diverse Women’s Health Device Portfolios

The combination of mammography device maker Hologic and cervical cancer test firm Cytyc will create a women's health powerhouse with $1.44 billion in combined annual revenues

More from Archive

More from Medtech Insight